Immunotherapy has ushered in a new era of hope for cancer patients. This innovative treatment method recruits the body’s own immune system to destroy malignant cells and allows precision in determining treatment protocols for various cancer tumors, including: lung cancers, breast cancers (triple negative), stomach cancers, head and neck cancers, and more.
Immunotherapy was crowned a scientific breakthrough by Science Magazine in 2013. In that same year, following more than three decades of research, the scientific community received dual confirmation of the efficacy of this treatment when it was proven that the changes which occur as a result of the interaction between the tumor and the body’s immune system could propagate an immune attack on the tumor. The second confirmation came in the form of evidence which shows that immunotherapy is not only effective for individuals, but is also appropriate for large groups of patients. This research heralded in new treatment concepts for cancer patients. Today, patients suffering from metastatic melanoma are routinely treated with immunotherapy drugs.